ππππ₯π’π ππ§πππ©ππ§πππ§π'π¬ ππ-ππ¨π°ππ«ππ ππ²ππ°πππ« πππ¦π©ππ’π π§: π...
β
Intalight has received CE Mark for its DREAM OCT platform, allowing the European Union to commercialize its use.
DREAM OCT has been used in over 160 peer-reviewed studies, which will enhance patient care by using its comprehensive imaging capabilities and diagnosing various ocular conditions.
The OCT system offers:
π130Β° ultrawide field single scan, delivering high-resolution OCT angiography (OCTA) images.
ποΈ12 mm super-depth scanning for detailed imaging of the choroid, retina, and a significant portion of the vitreous space.
βοΈ16.2 mm anterior segment scanning (in air), enabling comprehensive imaging from the cornea to the anterior vitreous in a single scan.
The introduction of the DREAM OCT platform will mean that patients will now have access to earlier, more accurate diagnosisβ, along with accelerated development of personalised treatment plans.